Multiple Myeloma, Cancer News Articles

Multiple Myeloma News


Multiple Myeloma News

FDA_drug approval

Darzalex Gets Approval for Additional Multiple Myeloma Indication

The FDA has expanded the approval of Darzalex (daratumumab; Janssen Biotech) to include use in combination with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant.
Next post in Multiple Myeloma News